Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax

Damjan Avsec(University of Ljubljana), Irena Mlinarič‐Raščan(University of Ljubljana)

Cell Death and Disease

October 8, 2022

10.1038/s41419-022-05287-6

Cited by 6

Related Papers

No related papers found

Powered by citation graph analysis